Belgium – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Bévacizumab
Published on December 19, 2025
Tender Description
Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif « Bévacizumab » pour injection en flacons « ready to use » de 100mg et 400mg.
Unlock Full Tender Insight
Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.
It's free to get started. No credit card required.
